Artificial Intelligence Tools for Refining Lung Cancer Screening

• Published in: Journal of clinical medicine Vol. 9; no. 12; p. 3860
• Main Authors: Espinoza, J. Luis, Dong, Le Thanh
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 27.11.2020; MDPI
• Subjects: Algorithms; Artificial intelligence; Asymptomatic; Biomarkers; Cellular biology; Chemotherapy; Clinical medicine; Clinical outcomes; Clinical trials; Disease; Lung cancer; Mammography; Medical diagnosis; Medical screening; Metastasis; Mortality; Mutation; Review; Smoking; Tobacco; Tomography; lung cancer imaging; computers assisted diagnosis; lung cancer screening; early cancer diagnosis; artificial intelligence and lung cancer
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm9123860

Nearly one-quarter of all cancer deaths worldwide are due to lung cancer, making this disease the leading cause of cancer death among both men and women. The most important determinant of survival in lung cancer is the disease stage at diagnosis, thus developing an effective screening method for early diagnosis has been a long-term goal in lung cancer care. In the last decade, and based on the results of large clinical trials, lung cancer screening programs using low-dose computer tomography (LDCT) in high-risk individuals have been implemented in some clinical settings, however, this method has various limitations, especially a high false-positive rate which eventually results in a number of unnecessary diagnostic and therapeutic interventions among the screened subjects. By using complex algorithms and software, artificial intelligence (AI) is capable to emulate human cognition in the analysis, interpretation, and comprehension of complicated data and currently, it is being successfully applied in various healthcare settings. Taking advantage of the ability of AI to quantify information from images, and its superior capability in recognizing complex patterns in images compared to humans, AI has the potential to aid clinicians in the interpretation of LDCT images obtained in the setting of lung cancer screening. In the last decade, several AI models aimed to improve lung cancer detection have been reported. Some algorithms performed equal or even outperformed experienced radiologists in distinguishing benign from malign lung nodules and some of those models improved diagnostic accuracy and decreased the false-positive rate. Here, we discuss recent publications in which AI algorithms are utilized to assess chest computer tomography (CT) scans imaging obtaining in the setting of lung cancer screening.